SurgLine International, Inc.
SGLN · OTC
7/31/2012 | 7/31/2011 | 7/31/2010 | 7/31/2009 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 34.4% | – | – | -770.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,165.1% | – | – | -14,687.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,408.9% | – | – | -24,857.9% |
| EPS Diluted | -0.001 | -0.01 | -0.01 | -0.01 |
| % Growth | 95% | 0% | 0% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |